There have been several reports that cataract development results from unregulated Ca2+ mediated degradation of lens crystallins. The calpain isoform m-calpain, a cysteine protease, is known to be a major player in cataract formation in rodent lenses and recent evidence indicates that over-activation by Ca2+ causes cataractogenesis in other mammals. Molecular modelling studies of seventeen analogues of compound SJA6017 (our lead compound) in a calpain model are compared to measured IC50 values against ovine calpain. The studies validated the potential of the ‘model’, method and defined activity criteria that could be used as a tool to select molecules to synthesize as potential calpain inhibitors. Using this screening methodology and two v...
This investigation involved the synthesis of potential CA clan cysteine inhibitors of m-calpain and...
Disruption of the connexin a3 (Cx46) gene (a3 (2/2)) in mice results in severe cataracts within the ...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...
Studies of 17 analoges of 3 (SJA6017) in an in silico calpain model are reconciled to measured IC(50...
Purpose: The aim of this study is to evaluate the therapeutic potential of a newly synthesized calpa...
The work in this thesis reports studies directed to developing a calpain cysteine protease inhibito...
The design and elaboration of a series of macrocyclic templates that exhibit a propensity to adopt a...
Calpains represent a family of non-lysosomal calcium-dependent proteases. Lenses from a variety of a...
Purpose. To compare effects of calpain inhibitors on in vitro light-scattering in rat lens soluble p...
Purpose.: We used sheep with an autosomal dominant gene for cortical cataract as an animal model to ...
This thesis reports the development of potent and selective inhibitors of m-calpain for the treatmen...
The absolute clarity of the lens of the eye is vital in the visual system. The unique structural and...
In the lens, soluble crystallin proteins are tightly packed and ordered allowing passage of light to...
AbstractThe purposes of this experiment were to: (1), characterize the peptide aldehyde SJA6017, N-(...
A series of N-heterocyclic dipeptide aldehydes 4–13 have been synthesised and evaluated as inhibitor...
This investigation involved the synthesis of potential CA clan cysteine inhibitors of m-calpain and...
Disruption of the connexin a3 (Cx46) gene (a3 (2/2)) in mice results in severe cataracts within the ...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...
Studies of 17 analoges of 3 (SJA6017) in an in silico calpain model are reconciled to measured IC(50...
Purpose: The aim of this study is to evaluate the therapeutic potential of a newly synthesized calpa...
The work in this thesis reports studies directed to developing a calpain cysteine protease inhibito...
The design and elaboration of a series of macrocyclic templates that exhibit a propensity to adopt a...
Calpains represent a family of non-lysosomal calcium-dependent proteases. Lenses from a variety of a...
Purpose. To compare effects of calpain inhibitors on in vitro light-scattering in rat lens soluble p...
Purpose.: We used sheep with an autosomal dominant gene for cortical cataract as an animal model to ...
This thesis reports the development of potent and selective inhibitors of m-calpain for the treatmen...
The absolute clarity of the lens of the eye is vital in the visual system. The unique structural and...
In the lens, soluble crystallin proteins are tightly packed and ordered allowing passage of light to...
AbstractThe purposes of this experiment were to: (1), characterize the peptide aldehyde SJA6017, N-(...
A series of N-heterocyclic dipeptide aldehydes 4–13 have been synthesised and evaluated as inhibitor...
This investigation involved the synthesis of potential CA clan cysteine inhibitors of m-calpain and...
Disruption of the connexin a3 (Cx46) gene (a3 (2/2)) in mice results in severe cataracts within the ...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...